The Association Between Molecular Typing of Treponema Pallidum and Treatment Efficacy and Clinical Findings
NCT ID: NCT02871505
Last Updated: 2018-11-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
150 participants
INTERVENTIONAL
2016-08-31
2020-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cefixime Clinical Trial
NCT04958122
Evaluation of a LAMP Assay for T. Pallidum. Pertenue
NCT04753788
A Study Evaluating Efficacy and Safety of CRO-SBT in the Treatment of Gonorrhea
NCT04202068
A 14 Day Early Bactericidal Activity Study of Nitazoxanide for the Treatment of Tuberculosis
NCT02684240
Staphylococcus Aureus Bacteraemia in Adults
NCT02098850
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Molecular subtyping (14d/f) of Treponema pallidum
Benzathine Penicillin G treatment
Benzathine Penicillin G
Molecular subtyping (others) of Treponema pallidum
Benzathine Penicillin G treatment
Benzathine Penicillin G
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Benzathine Penicillin G
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
2. Known allergy to penicillin
3. RPR titers were found to be 1:8 or less
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Peking Union Medical College Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jun Li
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Dermatology and Venereology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
Beijing, , China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PUMCH-2016079
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.